Chairman of Positron Corp. (POSC.OB) Confirms Partnership or Buy-Out Rumors
Positron Corp. is a molecular imaging company focused on nuclear cardiology. The company utilizes its proprietary product line to provide unique solutions to the nuclear medicine community ranging from imaging systems to radiopharmaceutical distribution. The molecular imaging market is currently a $5 billion market, with half of the revenue being generated in North America. Rumors of a lucrative buy-out or partnership occurring in the next week or so continue to swirl around Positron. The chairman of the board, Patrick G. Rooney, has confirmed in an interview with BioMedReports that his company “is currently in discussions with a potential partner in…